Hypercapnic acidosis attenuates pulmonary epithelial wound repair by an NF-κB dependent mechanism

Thorax

Volumn 64, Issue 11, 2009, Pages 976-982

  O'Toole, D ^a   Hassett, P ^a   Contreras, M ^a   Higgins, B D ^a   McKeown, S T W ^b   McAuley, D F ^b   O'Brien, T ^a   Laffey, J G ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACIDOSIS; ARTICLE; CARBON DIOXIDE TENSION; CELL DIVISION; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPERCAPNIA; HYPERCAPNIC ACIDOSIS; LUNG ALVEOLUS EPITHELIUM; LUNG VENTILATION; MITOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; WOUND HEALING;

EID: 72549102010     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.110304     Document Type: Article

References (36)

1. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308
2. Shibata K, Cregg N, Engelberts D, et al. Hypercapnic acidosis may attenuate acute lung injury by inhibition of endogenous xanthine oxidase. Am J Respir Crit Care Med 1998;158:1578-1584 (Pubitemid 28536623)
3. Laffey JG, Tanaka M, Engelberts D, et al. Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med 2000;162:2287-2294 (Pubitemid 32051702)
4. Laffey JG, Jankov RP, Engelberts D, et al. Effects of therapeutic hypercapnia on mesenteric ischemia-reperfusion injury. Am J Respir Crit Care Med 2003;168:1383-1390 (Pubitemid 37487336)
5. Laffey JG, Honan D, Hopkins N, et al. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am J Respir Crit Care Med 2004;169:46-56. (Pubitemid 38233888)
6. Ni Chonghaile M, Higgins BD, Costello JF, et al. Hypercapnic acidosis attenuates severe acute bacterial pneumonia-induced lung injury by a neutrophil-independent mechanism. Crit Care Med 2008;36:3135-3144
7. Ni Chonghaile M, Higgins BD, Costello J, et al. Hypercapnic acidosis attenuates lung injury induced by established bacterial pneumonia. Anesthesiology 2008;109:837-848
8. Wang Z, Su F, Bruhn A, et al. Acute hypercapnia improves indices of tissue oxygenation more than dobutamine in septic shock. Am J Respir Crit Care Med 2008;177:178-183
9. Costello J, Higgins BD, Contreras M, et al. Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit Care Med 2009;37:2412-2420
10. Laffey JG, Engelberts D, Duggan M, et al. Carbon dioxide attenuates pulmonary impairment resulting from hyperventilation. Crit Care Med 2003;31:2634-2640 (Pubitemid 37452844)
11. Sinclair SE, Kregenow DA, Lamm WJ, et al. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med 2002;166:403-408 (Pubitemid 34864435)
12. Laffey JG, Kavanagh BP. Carbon dioxide and the critically ill - too little of a good thing? Lancet 1999;354:1283-1286
13. Laffey JG, O'Croinin D, McLoughlin P, et al. Permissive hypercapnia - role in protective lung ventilatory strategies. Intensive Care Med 2004;30:347-356 (Pubitemid 38375607)
14. Doerr CH, Gajic O, Berrios JC, et al. Hypercapnic acidosis impairs plasma membrane wound resealing in ventilator-injured lungs. Am J Respir Crit Care Med 2005;171:1371-1377 (Pubitemid 40800509)
15. Costello ML, Mathieu-Costello O, West JB. Stress failure of alveolar epithelial cells studied by scanning electron microscopy. Am Rev Respir Dis 1992;145:1446-1455
16. Hotchkiss JR, Simonson DA, Marek DJ, et al. Pulmonary microvascular fracture in a patient with acute respiratory distress syndrome. Crit Care Med 2002;30:2368-2370 (Pubitemid 35191593)
17. Takeshita K, Suzuki Y, Nishio K, et al. Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-κB activation. Am J Respir Cell Mol Biol 2003;29:124-132 (Pubitemid 36783324)
18. Egan LJ, de Lecea A, Lehrman ED, et al. Nuclear factor-kappa B activation promotes restitution of wounded intestinal epithelial monolayers. Am J Physiol Cell Physiol 2003;285:C1028-35.
19. Lanchou J, Corbel M, Tanguy M, et al. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 2003;31:536-542 (Pubitemid 36232952)
20. Clark IM, Swingler TE, Sampieri CL, et al. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008;40:1362-1378
21. Jame AJ, Lackie PM, Cazaly AM, et al. Human bronchial epithelial cells express an active and inducible biosynthetic pathway for leukotrienes B4 and C4. Clin Exp Allergy 2007;37:880-892
22. Elkington PTG, Emerson JE, Lopez-Pascua LDC, et al. Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol 2005;175:5333-5340
23. Laffey JG, Engelberts D, Kavanagh BP. Buffering hypercapnic acidosis worsens acute lung injury. Am J Respir Crit Care Med 2000;161:141-146 (Pubitemid 30055916)
24. Kregenow DA, Rubenfeld GD, Hudson LD, et al. Hypercapnic acidosis and mortality in acute lung injury. Crit Care Med 2006;34:1-7. (Pubitemid 43032373)
25. Swenson ER. Therapeutic hypercapnic acidosis: pushing the envelope. Am J Respir Crit Care Med 2004;169:8-9.
26. Lang JD, Chumley P, Eiserich JP, et al. Hypercapnia induces injury to alveolar epithelial cells via a nitric oxide-dependent pathway. Am J Physiol Lung Cell Mol Physiol 2000;279:L994-1002. (Pubitemid 30952020)
27. O' Croinin DF, Nichol AD, Hopkins NO, et al. Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury. Crit Care Med 2008;36:2128-2135
28. O'Croinin DF, Hopkins NO, Moore MM, et al. Hypercapnic acidosis does not modulate the severity of bacterial pneumonia-induced lung injury. Crit Care Med 2005;33:2606-2612
29. Chen LW, Egan L, Li ZW, et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 2003;9:575-581 (Pubitemid 36597104)
30. Park GY, Christman JW. Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Targets 2006;7:661-668
31. Ishiyama T, Dharmarajan S, Hayama M, et al. Inhibition of nuclear factor kappaB by IkappaB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation. J Thorac Cardiovasc Surg 2005;130:194-201. (Pubitemid 40941690)
32. Matsuda N, Hattori Y, Jesmin S, et al. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Mol Pharmacol 2005;67:1018-1025 (Pubitemid 40410404)
33. Sadikot RT, Zeng H, Joo M, et al. Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J Immunol 2006;176:4923-4930
34. Caples SM, Rasmussen DL, Lee WY, et al. Impact of buffering hypercapnic acidosis on cell wounding in ventilator-injured rat lungs. Am J Physiol Lung Cell Mol Physiol 2009;296:L140-4.
35. Atabai K, Ishigaki M, Geiser T, et al. Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms. Am J Physiol Lung Cell Mol Physiol 2002;283:L163-9.
36. Kheradmand F, Folkesson HG, Shum L, et al. Transforming growth factor-alpha enhances alveolar epithelial cell repair in a new in vitro model. Am J Physiol 1994;267:L728-38.